Clinical trial · Interventional
Measuring Concerns of Cancer Patients Referred to Complementary Medicine Treatment Integrated Within Oncology Service
Measuring Concerns and Needs of Cancer Patients Referred to Complementary Medicine Treatment Integrated Within the Oncology Service
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In 2007, the Haifa and Western Galilee district of the CHS set out to test the feasibility of integrating complementary medicine (CM) within the CHS Oncology Service. In 2008, the CHS established the Integrative Oncology Program with the goal of addressing patient concerns and improving quality of life parameters during chemotherapy and advanced disease. The study hypothesis is that integrated medicine consultation and treatment provided within the oncology department may improve patients' concerns and well-being.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Quality of Life | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Complementary medicine consultation and treatment | Other | — | UNRESOLVED |
| Patients receiving conventional supportive care | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Complementary medicine counseling
- description
- Patients receiving chemotherapy who are referred by their oncology provider to complementary medicine consultation and treatment provided in addition to conventional supportive care
- interventionNames
- Other: Complementary medicine consultation and treatment
- type
- ACTIVE_COMPARATOR
- label
- Conventional supportive care
- description
- Patients receiving conventional supportive care
- interventionNames
- Other: Patients receiving conventional supportive care
Primary outcomes (3)
- measure
- MYCAW (Measure Yourself Concerns and Wellbeing)questionnaire
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with cancer diagnosis receiving chemotherapy and/or surgical treatment who are referred by their oncology provider to complementary medicine consultation * Age older than 18 years Exclusion Criteria: * Age younger than 18 years
References
Publications (9)
- DERIVEDKassem S, Gressel O, Samuels N, Stein N, Glaser B, Ben-Arye E. The impact of integrative medicine on quality of life in patients with diabetes mellitus and cancer. Support Care Cancer. 2026 Mar 17;34(4):335. doi: 10.1007/s00520-026-10511-6. PMID 41843227
- DERIVEDBen-Arye E, Greenberg D, Samuels N, Lopez AM, Simon-Tuval T. Adherence to Integrative Care, Oncology Healthcare Utilization, Opioid Use and Hospitalization. Integr Cancer Ther. 2025 Jan-Dec;24:15347354251387955. doi: 10.1177/15347354251387955. Epub 2025 Oct 28. PMID 41147326
- DERIVEDBen-Arye E, Lopez AM, Daoud N, Zoller L, Walker E, Davidescu M, Shulman K, Gressel O, Stein N, Brosh S, Schiff E, Samuels N. Identifying Factors Associated With Disparities in Access to Integrative Oncology Program. J Pain Symptom Manage. 2024 Jul;68(1):10-21. doi: 10.1016/j.jpainsymman.2024.03.018. Epub 2024 Mar 27. PMID 38552747
- DERIVEDHauzer M, Grimberg R, Samuels N, Keshet Y, Mordechai A, Dagash J, Ben-Arye E. Exploring primary care physician feedback following an integrative oncology consultation. Support Care Cancer. 2023 Oct 3;31(10):606. doi: 10.1007/s00520-023-08079-6. PMID 37787815
- DERIVEDBen-Arye E, Elly M, Gressel O, Reshef A, Shani Md M, Stein N, Saliba W, Samuels N. Exploring the effectiveness of a patient-tailored integrative oncology program on emotional distress during chemotherapy for localized cancer. Psychooncology. 2022 Feb;31(2):207-218. doi: 10.1002/pon.5794. Epub 2021 Aug 26. PMID 34435403
- DERIVEDKerner H, Samuels N, Ben Moshe S, Sharabi IS, Ben-Arye E. Impact of a patient-tailored complementary/integrative medicine programme on disturbed sleep quality among patients undergoing chemotherapy. BMJ Support Palliat Care. 2020 Sep;10(3):e21. doi: 10.1136/bmjspcare-2017-001351. Epub 2017 Jul 14. PMID 28710110
- Sharabi IS, Levin A, Schiff E, Samuels N, Agour O, Tapiro Y, Lev E, Keinan-Boker L, Ben-Arye E. Quality of life-related outcomes from a patient-tailored integrative medicine program: experience of Russian-speaking patients with cancer in Israel. Support Care Cancer. 2016 Oct;24(10):4345-55. doi: 10.1007/s00520-016-3274-3. Epub 2016 May 11.